Drugs & Diseases

Recent Drug Updates

  • burosumab (Crysvita) FDA approves Mab that targets the phosphaturic hormone FGF23 associated with X-linked hypophosphatemia
  • fostamatinib (Tavalisse) FDA approves spleen tyrosine kinase (SYK) inhibitor for adults with chronic immune thrombocytopenia (ITP)
  • nivolumab (Opdivo) Indication for advanced renal cell carcinoma expanded for use in combination with ipilimumab in previously untreated patients

Slideshow Collections